DeSmog

Drug makers may profit from disease in global warming scourge

authordefault
on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

Related Posts

on

A new report shows global spending on carbon capture and hydrogen subsidies "failed to make a dent in carbon emissions" after 50 years of research and development.

A new report shows global spending on carbon capture and hydrogen subsidies "failed to make a dent in carbon emissions" after 50 years of research and development.
on

The Tory leadership candidate has criticised the UK’s net zero targets while accepting donations from fossil fuel investors and climate denial funders.

The Tory leadership candidate has criticised the UK’s net zero targets while accepting donations from fossil fuel investors and climate denial funders.
on

A flagship climate scheme will cost taxpayers billions, with no guarantee of a meaningful impact on emissions.

A flagship climate scheme will cost taxpayers billions, with no guarantee of a meaningful impact on emissions.
on

Rupert Lowe has been campaigning against climate action while owning a heat pump supplier.

Rupert Lowe has been campaigning against climate action while owning a heat pump supplier.